EpiCast Report: Glaucoma - Epidemiology Forecast to 2026

EpiCast Report: Glaucoma - Epidemiology Forecast to 2026

  • December 2017 •
  • 44 pages •
  • Report ID: 3028419 •
  • Format: PDF
EpiCast Report: Glaucoma - Epidemiology Forecast to 2026

Summary
Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people. In glaucoma patients, the intraocular pressure (IOP)-the normal healthy eye pressure that is achieved when the eye produces a small amount of aqueous humor while letting an equal amount of fluid out of the eye-is disturbed due to mechanical compression and/or decreased blood flow to the optic nerve, thereby leading to increased IOP.

In the 7MM, the total prevalent cases of POAG will increase from 7,224,135 cases in 2016 to 8,549,547 cases in 2026, at an Annual Growth Rate (AGR) of 1.83%. In the 7MM, the total prevalent cases of PACG will increase from 2,644,012 cases in 2016 to 3,124,740 cases in 2026, at an AGR of 1.82%. It is forecast that all markets will see an increase in the total prevalent cases and diagnosed prevalent cases of POAG and PACG during the forecast period.

The report "EpiCast Report: Glaucoma - Epidemiology Forecast to 2026", provides an overview of the risk factors, comorbidities, and global and historical trends for glaucoma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of POAG and PACG, segmented by sex and age (40-49 years, 50-59 years, 60-69 years, 70-79 years, and ages 80 years and older) in these markets.

In addition, this report provides a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of glaucoma clinical types NTG, pre perimetric glaucoma (PPG), and SG. The report also includes the diagnosed incident cases of acute PACG.

Scope
- The Glaucoma EpiCast Report provides an overview of the risk factors and global trends of glaucoma in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of primary open-angle glaucoma (POAG) or primary angle-closure glaucoma (PACG), segmented by sex and age (40-49 years, 50-59 years, 60-69 years, 70-79 years, and ages 80 years and older) in these markets.

In addition, this report provides a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of glaucoma clinical types normal-tension glaucoma (NTG), pre perimetric glaucoma (PPG), and secondary glaucoma (SG). The report also includes the diagnosed incident cases of acute PACG.
- The glaucoma epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy
The Glaucoma EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global glaucoma market.
- Quantify patient populations in the global glaucoma market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for glaucoma therapeutics in each of the markets covered.
- Understand the population of glaucoma clinical types NTG, PPG, and SG.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.